Peter Altman - Apr 28, 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
President and CEO, Director
Signature
/s/ David McClung, by power of attorney
Stock symbol
BCDA
Transactions as of
Apr 28, 2022
Transactions value $
$8,004
Form type
4
Date filed
5/2/2022, 08:00 AM
Previous filing
Apr 18, 2022
Next filing
May 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Purchase $3.66K +2.3K +0.7% $1.59 330K Apr 28, 2022 Direct F1
transaction BCDA Common Stock Purchase $4.35K +2.7K +0.82% $1.61 333K Apr 29, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades ranging from $1.56 to $1.66 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 This transaction was executed in multiple trades ranging from $1.60 to $1.63 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.